Amryt Pharma (NASDAQ:AMYT) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Amryt Pharma missed estimated earnings by 150.0%, reporting an EPS of $-0.05 versus an estimate of $-0.02.

Revenue was up $10.70 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.08 which was followed by a 4.7% drop in the share price the next day.

Here's a look at Amryt Pharma's past performance:

To track all earnings releases for Amryt Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.